FOCUSED
ON YOUR HEALTH



ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

ATC code J: Antiinfectives for systemic use is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products.

Antiinfectives For Systemic Use

Solution for infusion - 400 mg/250 ml

Film coated tablets - 400mg 

Avacyn contains the active substance moxifloxacin hyrochloride, which belongs to a group of antibiotics called fluoroquinolones. Avacyn works by killing bacteria that cause infections. It is used in patients aged 18 years and above for treating the following bacterial infections when caused by bacteria against which moxifloxacin is active.

Avacyn is used for treating the following bacterial infections, when usual antibiotics cannot be used or have not worked:

  • infection of the sinuses (acute bacterial sinusitis);
  • acute exacerbations of chronic bronchitis;
  • community acquired penumonia outside the hospital (except severe cases);
  • mild to moderate infections of the female upper genital tract (pelvic inflammatory disease), including infections of the fallopian tubes and infections of the uterus mucous membrane        

Avacyn film-coated tablets are not sufficient on their own for treating this kind of infection, therefore, another antibiotic in addition to Avacyn film-coated tablets should be prescribed by your doctor for the treatment of infections of the female upper genital tract.

Avacyn film-coated tablets may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous moxifloxacin for the following indications:

  • complicated skin and skin structure infections;
  • community acquired pneumonia.

Avacyn tablets should not be used to initiate therapy for any type of infections of the skin and soft tissue or in severe infections of the lungs.

Oral suspension - (200 mg + 40 mg/5 ml)

Tablets - 100 mg

Doxyderma is a broad-spectrum antibiotic of the tetracycline group.

Doxyderma is indicated for infections caused by pathogens sensitive to doxycycline, especially by:

  • Infections of therespiratory airways andear-nose-throatarea
  • acute exacerbationsof chronicbronchitis
  • sinusitis
  • inflammation of the middle ear (Otitis media)
  • certain forms of pulmonary inflammation (pneumonia)caused by mycoplasma, rickettsia or chlamydia
  • Genitourinary tract infections urethritis caused by Chlamydia and Ureaplasma urealyticum
  • acute prostatitis
  • uncomplicated gonorrhea (especially with concurrent chlamydial infection)
  • infections of the female genital organs
  • syphilis, when there is penicillin allergy
  • urinary tract infection (only in case of proven sensitivity of the pathogen)
  • Infections of the gastrointestinal tract
  • Cholera
  • infections caused by Yersinia or Campylobacter
  • Shigella infection in proved sensitivity
  • Outpatient treatment of biliary tract infections
  • Skin diseases, also infected severe forms of acne vulgaris and rosacea
  • Conjunctivitis caused by chlamydia and trachoma
  • Diseases caused by Borrelia such as erythema chronicum migrans and Lyme disease (mainly caused by infections from bites)
  • Rare infections such as brucellosis, ornithosis, bartonellosis, listeriosis, rickettsiosis, melioidosis, plague, inguinal granuloma
  • Other diseases: malabsorption syndrome (diseases associated with dyspepsia) for example tropical Sprue and Whipple's disease.

Tablets - 100 mg

Doxyderma is a broad-spectrum antibiotic of the tetracycline group.

Doxyderma is indicated for infections caused by pathogens sensitive to doxycycline, especially by:

  • Infections of therespiratory airways andear-nose-throatarea
  • acute exacerbationsof chronicbronchitis
  • sinusitis
  • inflammation of the middle ear (Otitis media)
  • certain forms of pulmonary inflammation (pneumonia)caused by mycoplasma, rickettsia or chlamydia
  • Genitourinary tract infections urethritis caused by Chlamydia and Ureaplasma urealyticum
  • acute prostatitis
  • uncomplicated gonorrhea (especially with concurrent chlamydial infection)
  • infections of the female genital organs
  • syphilis, when there is penicillin allergy
  • urinary tract infection (only in case of proven sensitivity of the pathogen)
  • Infections of the gastrointestinal tract
  • Cholera
  • infections caused by Yersinia or Campylobacter
  • Shigella infection in proved sensitivity
  • Outpatient treatment of biliary tract infections
  • Skin diseases, also infected severe forms of acne vulgaris and rosacea
  • Conjunctivitis caused by chlamydia and trachoma
  • Diseases caused by Borrelia such as erythema chronicum migrans and Lyme disease (mainly caused by infections from bites)
  • Rare infections such as brucellosis, ornithosis, bartonellosis, listeriosis, rickettsiosis, melioidosis, plague, inguinal granuloma
  • Other diseases: malabsorption syndrome (diseases associated with dyspepsia) for example tropical Sprue and Whipple's disease.

 

Tablets - 250 mg

Tablets - 250 mg

Solution for injection - 40 mg/2 ml (40 000 UI)

Solution for injection - 80 mg/2 ml (80 000 UI)

Gentamycine is a potent bactericidal antibiotic with a wide range activity against both Gram-positive and Gram-negative strains including Staphylococcus aureus, Escherichia coli, Klebsiella, Proteus, and Pseudomonas species.

Gentamycine solution for injection is indicated for the following cases:

  • serious infections caused by aeruginosa, Proteus species, E. coli, Klebsiella species, Enterobacter species, Serratia species, Citrobacter species, Staphylococcus species;
  • acute and chronic infections of the urinary tract;
  • various systemic infections, such as: neonatal sepsis, peritonitis, meningitis;
  • bone and soft tissue infections, such as: acute osteomyelitis, wound infections (including burns);
  • bacterial septicemia;
  • respiratory tract infections;
  • empirical therapy for serious unknown infections.

Oral suspension - 125 mg/5 ml - 60 ml

Tablets - 250 mg

Film coated tablets - 500 mg

 

Solution for infusion - 500 mg / 100 ml

 

Solution for infusion - 0.5% - (5 g/1000 ml)

Metronidazole, a synthetic derivative of nitroimidazole, acts against gram-positive and gram-negative anaerobic microorganisms (Bacteroides species, including the B.fragilis bacterial group, Clostridium species, Eubacterium species, Peptococcus species, Peptostreptococcus species and against protozoan (Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia). The mechanism of action of metronidazole is not yet clear. It is thought that metronidazole inhibits the synthesis of DNA. It has bactericidal action.

Metronidazol is used in:

  • the treatment of infections caused by anaerobic microorganisms and infections from protozoa;
  • prevention of postoperative infections caused by anaerobic bacteria, especially bacteroides and anaerobic streptococci species;
  • the treatment of septicemia, bacteremia, peritonitis, brain abscess, necrotizing pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis and postoperative infections wounds when from them are isolated sensitive anaerobic pathogen microorganisms; urogenital trichomoniasis in females (trichomonial vaginitis) and in males; bacterial vaginosis (also known as non-specific vaginitis), or anaerobic vaginosis or Gardnerella vaginitis;
  • acute ulcerative gingivitis; leg ulcers, infected by anaerobic microorganisms;
  • acute dental infections (e.g. acute pericoronitis and acute apical infections);
  • all forms of amoebiasis (intestinal and extraintestinal disease) and those of asymptomatic cyst holders;
  • giardiasis;
  • treatment of Helicobacter pylori, in combination with other medicines.

Solution for infusion - 5 g/1000 ml - 100 ml

Metronidazole, a synthetic derivative of nitroimidazole, acts against gram-positive and gram-negative anaerobic microorganisms (Bacteroides species, including the B.fragilis bacterial group, Clostridium species, Eubacterium species, Peptococcus species, Peptostreptococcus species and against protozoan (Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia). The mechanism of action of metronidazole is not yet clear. It is thought that metronidazole inhibits the synthesis of DNA. It has bactericidal action.

Metronidazol is used in:

  • the treatment of infections caused by anaerobic microorganisms and infections from protozoa;
  • prevention of postoperative infections caused by anaerobic bacteria, especially bacteroides and anaerobic streptococci species;
  • the treatment of septicemia, bacteremia, peritonitis, brain abscess, necrotizing pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis and postoperative infections wounds when from them are isolated sensitive anaerobic pathogen microorganisms; urogenital trichomoniasis in females (trichomonial vaginitis) and in males; bacterial vaginosis (also known as non-specific vaginitis), or anaerobic vaginosis or Gardnerella vaginitis;
  • acute ulcerative gingivitis; leg ulcers, infected by anaerobic microorganisms;
  • acute dental infections (e.g. acute pericoronitis and acute apical infections);
  • all forms of amoebiasis (intestinal and extraintestinal disease) and those of asymptomatic cyst holders;
  • giardiasis;
  • treatment of Helicobacter pylori, in combination with other medicines.
Results 1 - 15 of 27

Recently viewed

Film coated tablets - 180 mg

 

Tablets - 0.5 mg

Tablets - 25 mg

Rectal solution - 5 mg/2.5 ml

Solution - 10 %